Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Amit S, Regev-Yochay G, Afek A, Kreiss Y, et al. Lancet 2021 Feb 18. pii: S0140-6736(21)00448.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Amit S, Regev-Yochay G, Afek A, Kreiss Y, et al. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet 2021 Feb 18. pii: S0140-6736(21)00448.
PMID: 33610193